Human Immunodeficiency Virus Acquisition Associated with Genital Ulcer Disease and Herpes Simplex Virus Type 2 Infection: A Nested Case-Control Study in Rakai, Uganda

Journal of Infectious Diseases

Volumn 188, Issue 10, 2003, Pages 1492-1497

  Serwadda, David ^a   Gray, Ronald H ^c   Sewankambo, Nelson K ^a   Wabwire Mangen, Fred ^a   Chen, Michael Z ^c   Quinn, Thomas C ^d,e   Lutalo, Tom ^b   Kiwanuka, Noah ^b   Kigozi, Godfrey ^b   Nalugoda, Fred ^b   Meehan, Mary P ^f   Morrow, Rhoda Ashley ^g   Wawer, Maria J ^f  

^a MAKERERE UNIVERSITY   (Uganda)

^b UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f University of Washington ^*  (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; FEMALE; GENITAL ULCER; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK; SEROCONVERSION; SERODIAGNOSIS; SYMPTOMATOLOGY; UGANDA; VIRUS LOAD; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; BLOTTING, WESTERN; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; INTERVIEWS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, VIRAL; RURAL POPULATION; UGANDA;

EID: 10744228287     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/379333     Document Type: Article

References (21)

1. Rottingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis 2001; 28:579-97.
2. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
3. Korenromp EL, de Vlass SJ, Nagelkerke NJ, Habbema JD. Estimating the magnitude of STD cofactor effects on HIV transmission: how well can it be done? Sex Transm Dis 2001; 28:613-21.
4. Kamali A, Nunn AJ, Mulder DW, Van Dyck E, Dobbins JG, Whitworth JA. Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population. Sex Transm Infect 1999; 75:98-102.
5. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med 1998; 339:33-9.
6. McFarland W, Gwanzura L, Basset MT, et al. Prevalence and incidence of herpes simples virus type 2 infection among male Zimbabwean factory workers. J Infect Dis 1999; 180:1459-65.
7. Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomized community trial. Rakai Project Study Group. Lancet 1999; 353:525-35.
8. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002; 185:45-52.
9. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol 1988; 26:662-7.
10. Schacker T, Zeh J, Hu H, Shaughnessy M, Corey L. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis 2002; 186: 1718-25.
11. Hitti J, Watts DH, Burchett SK, et al. Herpes simplex virus seropositivity and reactivation at delivery among pregnant women infected with human immunodeficiency virus-1. Am J Obstet Gynecol 1997; 177:450-4.
12. Conant MA, Schacker TW, Murphy RL, Gold J, Crutchfield LT, Crooks RJ. Valaciclovir versus acyclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials. Int J STD AIDS 2002; 13:12-21.
13. Gray RH, Wawer MJ, Sewankambo NK, et al. Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic STDs in Rakai, Uganda. AIDS 1999; 13:2113-23.
14. Orroth KK, Gavyole A, Todd J, et al. Syndromic treatment of sexually transmitted diseases reduces the proportion of incident HIV infections attributable to these diseases in rural Tanzania. AIDS 2000; 14:1429-37.
15. Grosskurth H, Gray R, Hayes R, Mabey D, Wawer M. Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. Lancet 2000; 355:81-7.
16. Schacker T. The role of HSV in the transmission and progression of HIV. Herpes 2001; 8:46-9.
17. Mole L, Ripich S, Margolis D, Holodniy M. The impact of herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997; 176:766-70.
18. Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001; 357:1149-53.
19. Pilcher CD, Eron JJ, Vemazza PL, et al. Sexual transmission during the incubation period of primary HIV infection. JAMA 2001; 286:1713-14.
20. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167-70.
21. Craib KJP, Strathdee SA, Hogg RS, et al. Serum levels of human immunodeficiency virus type 1 (HIV-1) RNA after seroconversion: a predictor of long-term mortality in HIV infection. J Infect Dis 1997; 176: 798-800.